We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.ContinueLearn More X
Lubrizol LifeSciences is a preferred medical device and pharmaceutical solutions partner, helping customers from concept to commercialization by offering polymer customization, drug-eluting device development and contract manufacturing services. This year, Lubrizol LifeSciences will highlight a strong commitment to the interventional catheters, long-term implant and drug-eluting device markets.
LifeSciences has invested significantly to expand its global development and manufacturing facilities to better serve the growing medical device market by expanding its silicone and thermoplastic capacity with a 71,000-square foot facility. This facility features enhanced product development capabilities, cellular manufacturing and high-efficiency production lines in Class 7 and 8 clean rooms.
“When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process,” states Uwe Winzen, general manager, Lubrizol LifeSciences. “Our long history of polymer expertise and medical device manufacturing, enhanced with recent investments, makes Lubrizol LifeSciences a full-service development partner for the next generation of medical devices, including long-term implantable and drug-eluting device innovations.”
Additionally, at Medtec Europe, LifeSciences will highlight a comprehensive suite of services focused on the development of advanced drug/device combination solutions including analytical services for coating characterization, drug release testing and more.